Cerebrolysin

FDA APPROVAL PENDING

Well Studied

Cognitive

Longevity

Cognitive

Cerebrolysin

Longevity

Amino acid sequence

Amino acids

0da

Molecular weight

Blend

Type

Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery, traumatic brain injury, and cognitive enhancement. Used clinically in 50+ countries.

Top researched benefits

Overview of Cerebrolysin

IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.

Cognitive

Meta-analyses show modest cognitive improvements, though clinical significance remains debated.
Multiple RCTs demonstrate significant ADAS-cog and CIBIC+ improvements.
Large meta-analysis shows significant NIHSS improvements; other studies found no functional benefit.

Neuroprotection

Largest meta-analysis (1,879 patients) shows NIHSS benefits; independent analysis found no mRS improvement.
Multiple trials including CAPTAIN series confirm GCS/GOS improvements.
Pilot trial shows promising 6-month outcomes; requires larger confirmatory studies.

Recovery

Some studies show enhanced recovery; results vary significantly between trials.
Early administration within 72 hours shows better outcomes than delayed treatment.

Storage

Room temperature ≤25°C, protected from light in original carton - never freeze

Frequency

Once daily for acute conditions; 5 days weekly for chronic conditions

Typical Dose

10-50mL depending on indication (stroke/TBI higher doses)

Cycle Duration

7-30 days depending on condition (stroke/TBI 10-30 days, dementia 4 weeks)

Chemical Makeup

Key benefits

Direct brain delivery

Standardized dosing

Extensive clinical evidence

Ready-to-use formulation

Used clinically in 50+ countries

Community interest

This peptide is still gaining traction in the community.

Neuropeptide Preparation | Neurological Recovery

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

Cerebrolysin Molecular Information

View the scientifc details of Cerebrolysin.

Amino Acids

Cerebrolysin

Asx

Position 1

Ile

Position 2

Pyl

Position 3

Ala

Position 4

Cys

Position 5

Thr

Position 6

Ile

Position 7

Val

Position 8

Glu

Position 9

Pro

Position 10

Glu

Position 11

Pro

Position 12

Thr

Position 13

Ile

Position 14

Asp

Position 15

Glu

Position 16

Met

Position 17

Ile

Position 18

Position 19

Thr

Position 20

Sec

Position 21

Arg

Position 22

Glu

Position 23

Amino acid sequence

Aspartic acid or AsparaginePosition 1

IsoleucinePosition 2

PyrrolysinePosition 3

AlaninePosition 4

CysteinePosition 5

ThreoninePosition 6

IsoleucinePosition 7

ValinePosition 8

Glutamic acidPosition 9

ProlinePosition 10

Glutamic acidPosition 11

ProlinePosition 12

ThreoninePosition 13

IsoleucinePosition 14

Aspartic acidPosition 15

Glutamic acidPosition 16

MethioninePosition 17

IsoleucinePosition 18

?Position 19

ThreoninePosition 20

SelenocysteinePosition 21

ArgininePosition 22

Glutamic acidPosition 23

Molecular Weight

0Da

Chain Length

23Amino Acids

Type

Blend

Cerebrolysin Protocols

Primary administration route with well-established protocols for direct brain delivery via IV/IM.

Goal	Dosage	Frequency	Route
Small Volume IV	10	1 week range	Undiluted IV slow push over 3 minutes
Intramuscular	5	1 week range	Undiluted IM injection over 3 minutes
Acute Stroke	20	10 week range	IV infusion (diluted to 100mL minimum)
Traumatic Brain Injury	20	7 week range	IV infusion (diluted to 100mL minimum)
Alzheimer's Disease	10	5 week range	IV injection/infusion (2-4 cycles yearly)
Vascular Dementia	10	5 week range	IV injection/infusion (2-4 cycles yearly)

Reconstitution Instructions

Materials needed:

Cerebrolysin ampoules (5, 10, or 20 mL)Saline, Ringer solution, or 5% glucose (minimum 100 mL for infusion)Disposable one-way IV infusion sets and cannulasSterile syringes and alcohol swabs

Steps to reconstitute

Break ampoule and extract Cerebrolysin immediately before use
For direct injection: Up to 10 mL IV undiluted (slow 3 minutes) or 5 mL IM
For infusion: Dilute 10-50 mL to minimum 100 mL with compatible solution
Start infusion immediately after dilution—infuse within 15 minutes
Flush IV catheter with sodium chloride before and after administration
Use disposable one-way infusion sets; discard after use

Cerebrolysin Cycle

The Cerebrolysin Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 1-2: Initial neuroprotective effects; possible mild side effects (dizziness, agitation)
Week 2-4: Neurological improvements become apparent; cognitive function may begin to improve
Week 4-8: Continued recovery; motor function improvements in stroke/TBI patients
Week 8-12: Sustained benefits; cognitive enhancement plateaus in chronic conditions

Dosing tools

Cerebrolysin Blend Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

< 1 units

0.000 mL

BAC Water Added (mL)

1 mL

2 mL

3 mL

5 mL

Custom

Cerebrolysin Composition

(0mg vial)

Conversion: 1,000 mcg = 1 mg

Results

Safe concentration range

Concentration

—

Doses per vial

—

Total blend to inject

—

You'll get:

How it works

Select a blend, enter how much water you added, then specify the dose you want of any single component. The calculator figures out how much total blend to inject and shows what you'll get of each peptide.

Dosing Guidance

Recommended Schedule

Once daily for acute conditions; 5 days weekly for chronic conditions

Supply Duration

This vial provides 0 doses (0-day supply at 250 mcg daily)

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Side effects

Contraindications

: Epilepsy
: Severe renal insufficiency
: History of severe allergic reactions to porcine products

Stop signs

: Severe allergic reactions (anaphylaxis, severe rash)
: New onset seizure activity
: Significant cardiovascular events during administration
: Severe renal dysfunction or worsening kidney function

Bad signs

Frozen product or improper storage—never freezeMixing with incompatible solutions (amino acids, vitamins, cardiovascular medications)

Was it helpful?Yes

Comments

0.0

0 reviews

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

CerebrolysinResearch References

Cerebrolysin is a well studied compound

4Research references

Cerebrolysin

Cerebrolysin is a well studied compound

CAPTAIN II Trial - Traumatic Brain Injury

Randomized controlled trial demonstrating efficacy and safety in moderate-severe TBI with improved GCS and GOS scores.

2020

Nine-Trial Stroke Meta-Analysis - Positive Results

Largest positive meta-analysis showing significant neurological improvements in 1,879 stroke patients with NNT=7.7.

2017

Conflicting Stroke Meta-Analysis - Neutral Results

Independent meta-analysis of 1,779 patients found no significant benefits in functional outcomes (mRS/BI).

2017

TBI Systematic Review - Positive Outcomes

Analysis of 8,749 TBI patients across 10 studies confirms statistically significant GCS/GOS improvements.

2023